| ¿µ¹® | fetal monitoring | ÇÑ±Û | žư¨½Ã |
|---|---|---|---|
| ¼³¸í | ÀӽŠÁßÀ̳ª ºÐ¸¸ ÁßÀÇ Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ» žư¨½Ã¶ó°í ÇÑ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¹æ¹ýÀÌ Àִµ¥ Å©°Ô ºÐ¸¸Àü žư¨½Ã¿Í ºÐ¸¸Áß Å¾ư¨½Ã·Î Å©°Ô ³ª´«´Ù. 1. ºÐ¸¸Àü žư¨½Ã´Â ºÐ¸¸Çϱâ ÀÌÀüÀÇ Å¾ÆÀÇ »óŸ¦ °Ë»çÇÏ´Â ¹æ¹ýÀ¸·Î ´ÙÀ½°ú °°Àº ¿©·¯ °¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. 1)¾ç¼öõÀÚ-ÁÖ»ç±â¸¦ ÀÌ¿ëÇØ¼ »ê¸ðÀÇ ¹è¸¦ ÅëÇØ¼ ¾ç¼ö¸¦ ¾ò¾î¼ ºÐ¼®ÇÏ¿© žÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â ¹æ¹ý. ÀӽŠ15ÁÖ À̻󿡼 ½Ç½ÃÇÒ ¼ö°¡ ÀÖ´Ù. 2)ÅÈÁÙõÀÚ-ÃÊÀ½ÆÄ°Ë»ç¸¦ ½Ç½ÃÇÏ¿© ¿µ»óÀ» º¸¸é¼ ÅÈÁÙ¼Ó¿¡ ¹Ù´ÃÀ» ³Ö¾î¼ ±×°÷ÀÇ Ç÷°üÀ» ã¾Æ Ç÷¾×À» äÃëÇÏ¿© °Ë»çÇÏ´Â ¹æ¹ý. 3)½ºÆ®·¹½º°Ë»ç-žƵµ Àڱüӿ¡¼ ¿îµ¿À» ÇÑ´Ù. ±×¸®°í Á¤»óÀûÀ¸·Î žư¡ Àڱüӿ¡¼ ¿îµ¿À» ÇÒ °æ¿ì¿¡´Â žÆÀÇ ½ÉÀå ¹Úµ¿ÀÌ »¡¶óÁö°Ô µÈ´Ù. žÆÀÇ ¿îµ¿°ú žÆÀÇ ½ÉÀå¹Úµ¿À» µ¿½Ã¿¡ °¨½ÃÇÏ¿© ¿îµ¿½Ã¿¡ žÆÀÇ ½ÉÀå¹Úµ¿ÀÌ »¡¶óÁö´Â °¡¸¦ ¾Ë¾Æº¸´Â °ÍÀÌ´Ù. 4)žÆÃ»°¢Àڱذ˻ç-30ÁÖ ÀÌ»óÀÌ µÈ žƴ ¼Ò¸®ÀÇ Àڱؿ¡ ´ëÇØ¼ ¹ÝÀÀÀ» ÇÑ´Ù. Áï ¼Ò¸®¸¦ µé·ÁÁÖ¾úÀ» °æ¿ì¿¡ žư¡ ¹ÝÀÀÀ» ÇØ¼ ½ÉÀåÀÇ ¹Úµ¿¼ö°¡ Áõ°¡¸¦ ÇÑ´Ù. 5)¼öÃེƮ·¹½º°Ë»ç-Á¤»óÀûÀΠžƴ ÀÚ±ÃÀÌ ¼öÃàÇϸé ÀÌ¿¡ ¹ÝÀÀÀ» ÇØ¼ ½É¹Ú¼ö°¡ º¯ÈÇÑ´Ù. À̰ÍÀ» ÀÌ¿ëÇÏ¿© žÆÀÇ »óŸ¦ °Ë»çÇÏ´Â ¹æ¹ýÀÌ´Ù. 2. ºÐ¸¸Áß Å¾ư¨½Ã ºÐ¸¸µµÁß¿¡ žÆÀÇ °Ç°»óŸ¦ °¨½ÃÇÏ´Â °ÍÀÌ´Ù. ´ëü·Î ºÐ¸¸µµÁß¿¡ žư¡ Àú»ê¼ÒÁõÀ̳ª ¿©·¯ °¡Áö Ãæ°ÝÀ» ¹Þ´Â °æ¿ì°¡ ¸¹À¸¹Ç·Î ºÐ¸¸µµÁßÀÇ Å¾ư¨½Ã´Â Áß¿äÇÑ Àǹ̸¦ °¡Áø´Ù. 1)ÀüÀڽĞư¨½Ã-Àü±âÀû ÀåÄ¡¸¦ ÀÌ¿ëÇÏ¿© žÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ¸·Î °¨½ÃÀÇ ´ë»óÀº ÀÚ±ÃÀÇ ¼öÃà°ú žÆÀÇ ½ÉÀå¹Úµ¿¼öÀÌ´Ù. 2)žƸӸ®µ¤°³ Ç¥º»Ã¤Ãë Ç÷¾×-ºÐ¸¸µµÁß¿¡ žÆÀÇ µÎÇÇÀÇ Ç÷°ü¿¡¼ Ç÷¾×À» äÃëÇÏ¿© °Ë»ç¸¦ ÅëÇØ¼ žÆÀÇ »óŸ¦ ¾Æ´Â ¹æ¹ýÀÌ´Ù. ÁÖ·Î °Ë»ç¸¦ ÇàÇÏ´Â Á¾¸ñÀº Ç÷¾×ÀÇ pHÀÌ´Ù. |
||
| AIDSDRUGS | clinical trials of acquired immunodeficiency drugs [MEDLARS data base] |
|---|---|
| AIDSTRIALS | clinical trials of acquired immunodeficiency syndrome drugs [MEDLARS data base] |
| MDS | Master of Dental Surgery; maternal deprivation syndrome; medical data screening; medical data system... |
| CTN | calcitonin; clinical trials notification; computer tomography number; continuous noise |
| CTS | carpal tunnel syndrome; clinical trials support [program]; composite treatment score; computed tomog... |
| ACTG | AIDS Clinical Trials Group |
|---|---|
| CCTs | Controlled clinical trials |
| PACTG | Paediatric AIDS Clinical Trials Group |
| RCT | Randomized controlled clinical trials |
| BI-RADS | Breast Imaging Reporting And Data System |
| clinical research trials | Evaluating the safety and effectiveness of medications or medical devices by monitoring their effects on large groups of people. Clinical medical trials sponsored by the U. S. Government are listed on a web site of the National Institutes of Health (NIH). The NIH Clinical Centre intends to make details of current clinical research studies for various diseases available over the Internet to increase opportunities for patients and physicians to participate in clinical investigations. (12 Dec 1998) |
|---|---|
| clinical trials | Medical research studies conducted with volunteers. Each study is designed to answer scientific questions and to find better ways to prevent, detect, or treat cancer. (12 Dec 1998) |
| clinical trials, phase I | Studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the u.s. And in other countries. (12 Dec 1998) |
| clinical trials, phase II | Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the u.s. And in other countries. (12 Dec 1998) |
| clinical trials, phase III | Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the u.s. And in other countries. (12 Dec 1998) |
| clinical trials, phase IV | Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the u.s. And in other countries. (12 Dec 1998) |
| controlled clinical trials | Clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterised as randomised controlled trials. However, trials employing treatment allocation methods such as coin flips, odd-even numbers, patient social security numbers, days of the week, medical record numbers, or other such pseudo- or quasi-random processes, are simply designated as controlled clinical trials. (12 Dec 1998) |
| professional staff committees | Committees of professional personnel who have responsibility for determining policies, procedures, and controls related to professional matters in health facilities. (12 Dec 1998) |
| ethics committees | Committees whose purpose may be to direct educational programs; to provide forums for discussion of ethical issues among hospital or medical professionals and others; to serve in an advisory capacity and/or as a resource to health professionals involved in biomedical decision making; or to review and evaluate institutional experiences related to decisions having biomedical ethical implications. (12 Dec 1998) |
| randomised controlled trials | Clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Treatment allocations using coin flips, odd-even numbers, patient social security numbers, days of the week, medical record numbers, or other such pseudo- or quasi-random processes, are not truly randomised and trials employing any of these techniques for patient assignment are designated simply controlled clinical trials. (12 Dec 1998) |
| automatic data processing | Data processing largely performed by automatic means. (12 Dec 1998) |
| Physicians Data Query | <oncology> A free enquiry service originating in the USA for physicians on all state of the art cancer diagnostic, preventive and treatment methods. The documents are provided by the US National Cancer Institute and includes electronic access of various forms. WWW: CancerNET Acronym: PDQ (12 Jan 1998) |
| molecular sequence data | Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as genbank, european molecular biology laboratory (embl), national biomedical research foundation (nbrf), or other sequence repositories. (12 Dec 1998) |
| national practitioner data bank | A databank established by the health care quality improvement act of 1986 authorizing the department of health and human services to collect and release information on the professional competence and conduct of physicians, dentists, nurses, and other health care practitioners. The data include adverse actions on physicians' malpractice, licensure, hospital privileges, concealing of pertinent information, and the like. (12 Dec 1998) |
| subjective assessment data | Those facts that are observable and measurable by the nurse. (05 Mar 2000) |
Synonyms : Data Monitoring Committees, Board, Safety Monitoring, Boards, Safety Monitoring, Committee, Data Monitoring, Committees, Data Monitoring, Data Monitoring Committee, Monitoring Board, Safety, Monitoring Boards, Safety, Monitoring Committee, Data
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|